Restoration of microRNA-708 sensitizes ovarian cancer cells to cisplatin via IGF2BP1/Akt pathway-Reference-Cited by-同舟云学术

Restoration of microRNA-708 sensitizes ovarian cancer cells to cisplatin via IGF2BP1/Akt pathway

Published:2017-08-17 Issue:10 Volume:41 Page:1110-1118
ISSN:1065-6995
Container-title:Cell Biology International
language:en
Short-container-title:Cell Biol Int

Author:

Qin Xuying¹,Sun Linlin¹,Wang Jing²

Affiliation:

1. Department of Obstetrics and Gynecology; Liaocheng People's Hospital; Liaocheng People's Republic of China

2. Department of Obstetrics and Gynecology; Dezhou People's Hospital; Dezhou People's Republic of China

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cbin.10819/fullpdf

Reference28 articles.

1. Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells;Arjumand;Oncotarget,2016

2. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells;Asselin;Cancer Res,2001

3. Reversal of cisplatin resistance with a BH3 mimetic, (−)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL;Bauer;Mol Cancer Ther,2005

4. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression;Bell;Cell Mol Life Sci,2013

5. Chemoresistance and targeted therapies in ovarian and endometrial cancers;Brasseur;Oncotarget,2017

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment;Genes & Diseases;2024-03

2. The Double Face of miR-708: A Pan-Cancer Player with Dissociative Identity Disorder;Genes;2022-12-16

3. The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance – A focus on signaling pathways interplay;Pathology - Research and Practice;2022-12

4. RRP9 promotes gemcitabine resistance in pancreatic cancer via activating AKT signaling pathway;Cell Communication and Signaling;2022-11-24

5. Targeting the “undruggable”: RNA-binding proteins in the spotlight in cancer therapy;Seminars in Cancer Biology;2022-11